Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹27,959.6
₹59,412 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,660.3
₹33,237 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹740.9
₹6,716 Cr
Pharmaceuticals & Drugs
₹423.3
₹6,662 Cr
Pharmaceuticals & Drugs
₹394.5
₹3,601 Cr
Pharmaceuticals & Drugs
₹310.2
₹3,472 Cr
Pharmaceuticals & Drugs
₹102.0
₹2,619 Cr
Pharmaceuticals & Drugs
₹767.7
₹438 Cr
Pharmaceuticals & Drugs
₹67.0
₹190 Cr
Pharmaceuticals & Drugs
₹37.3
₹182 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,660.3
₹4,973 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹423.3
₹4,108 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹394.5
₹2,477 Cr
Pharmaceuticals & Drugs
₹740.9
₹1,906 Cr
Pharmaceuticals & Drugs
₹310.2
₹707 Cr
Pharmaceuticals & Drugs
₹102.0
₹224 Cr
Pharmaceuticals & Drugs
₹37.3
₹111 Cr
Pharmaceuticals & Drugs
₹27,959.6
₹6,714 Cr
Pharmaceuticals & Drugs
₹767.7
₹316 Cr
Pharmaceuticals & Drugs
₹67.0
₹428 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,660.3
₹974 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹423.3
₹323 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹740.9
₹242 Cr
Pharmaceuticals & Drugs
₹394.5
₹199 Cr
Pharmaceuticals & Drugs
₹310.2
₹151 Cr
Pharmaceuticals & Drugs
₹102.0
₹144 Cr
Pharmaceuticals & Drugs
₹37.3
₹5 Cr
Pharmaceuticals & Drugs
₹27,959.6
₹1,509 Cr
Pharmaceuticals & Drugs
₹767.7
₹-15 Cr
Pharmaceuticals & Drugs
₹67.0
₹4 Cr

You may also like the below Video Courses